# Insulin for Hyperglycemia in Stroke Trial

> **NCT04834362** · PHASE4 · COMPLETED · sponsor: **National Institute of Neurosciences and Hospital, Dhaka** · enrollment: 452 (actual)

## Conditions studied

- Hyperglycemia
- Stroke, Acute

## Interventions

- **DRUG:** Analog Insulin
- **DRUG:** Human insulin

## Key facts

- **NCT ID:** NCT04834362
- **Lead sponsor:** National Institute of Neurosciences and Hospital, Dhaka
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-05
- **Primary completion:** 2021-06-20
- **Final completion:** 2021-06-25
- **Target enrollment:** 452 (ACTUAL)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834362, "Insulin for Hyperglycemia in Stroke Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04834362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*